Loading company…
Otologic Pharmaceutics, founded in 2014 in Oklahoma City, develops pharmaceutical treatments for ear-related conditions.
Founded in 2014 and headquartered in Oklahoma City, US, Otologic Pharmaceutics develops pharmaceutical products for otological conditions, such as ear infections and hearing loss, sold to hospitals, clinics and pharmacies. It raised USD 4.1 million in Series A funding in April 2014, co-led by Accele Biopharma and i2E Inc., with participation from the Oklahoma Life Science Fund. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in